These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 20177469)

  • 1. Topical delivery of flurbiprofen from pluronic lecithin organogel.
    Pandey MS; Belgamwar VS; Surana SJ
    Indian J Pharm Sci; 2009 Jan; 71(1):87-90. PubMed ID: 20177469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pluronic lecithin organogel as a topical drug delivery system.
    Pandey M; Belgamwar V; Gattani S; Surana S; Tekade A
    Drug Deliv; 2010 Jan; 17(1):38-47. PubMed ID: 22747074
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Propolis organogel as a novel topical delivery system for treating wounds.
    Balata G; El Nahas HM; Radwan S
    Drug Deliv; 2014 Feb; 21(1):55-61. PubMed ID: 24295500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Formulation and evaluation of novel controlled release of topical pluronic lecithin organogel of mefenamic acid.
    Jhawat V; Gupta S; Saini V
    Drug Deliv; 2016 Nov; 23(9):3573-3581. PubMed ID: 27494650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preparation and evaluation of tubular micelles of pluronic lecithin organogel for transdermal delivery of sumatriptan.
    Agrawal V; Gupta V; Ramteke S; Trivedi P
    AAPS PharmSciTech; 2010 Dec; 11(4):1718-25. PubMed ID: 21128126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Formulation and evaluation of lecithin organogel for topical delivery of fluconazole.
    Jadhav KR; Kadam VJ; Pisal SS
    Curr Drug Deliv; 2009 Apr; 6(2):174-83. PubMed ID: 19450224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparation and in vitro evaluation of a pluronic lecithin organogel containing ricinoleic acid for transdermal delivery.
    Boddu SH; Bonam SP; Wei Y; Alexander K
    Int J Pharm Compd; 2014; 18(3):256-61. PubMed ID: 25306775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, Development and
    Chauhan S; Jhawat V; Singh RP; Yadav A; Garg V
    Recent Adv Drug Deliv Formul; 2024; 18(1):50-60. PubMed ID: 38284692
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Topical delivery of aceclofenac from lecithin organogels: preformulation study.
    Shaikh IM; Jadhav KR; Gide PS; Kadam VJ; Pisal SS
    Curr Drug Deliv; 2006 Oct; 3(4):417-27. PubMed ID: 17076644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Physical Stability and Release Profile of Compounded Gabapentin Containing Pluronic Lecithin Organogel for Neuropathic Pain Management.
    Hong EJ; Sumanasekera W; Le UM
    Int J Pharm Compd; 2022; 26(1):65-71. PubMed ID: 35081046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Self-Assembling Organogels Based on Pluronic and Lecithin for Sustained Release of Etodolac: In Vitro and In Vivo Correlation.
    Mohammed AM; Faisal W; Saleh KI; Osman SK
    Curr Drug Deliv; 2017; 14(7):926-934. PubMed ID: 27593184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Formulation and clinical evaluation of silymarin pluronic-lecithin organogels for treatment of atopic dermatitis.
    Mady FM; Essa H; El-Ammawi T; Abdelkader H; Hussein AK
    Drug Des Devel Ther; 2016; 10():1101-10. PubMed ID: 27022248
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aceclofenac organogels: in vitro and in vivo characterization.
    Shaikh IM; Jadhav SL; Jadhav KR; Kadam VJ; Pisal SS
    Curr Drug Deliv; 2009 Jan; 6(1):1-7. PubMed ID: 19418950
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mangiferin-Loaded Smart Gels for HSV-1 Treatment.
    Sicurella M; Sguizzato M; Cortesi R; Huang N; Simelière F; Montesi L; Marconi P; Esposito E
    Pharmaceutics; 2021 Aug; 13(9):. PubMed ID: 34575399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Formulation and evaluation of flurbiprofen microemulsion.
    Ambade KW; Jadhav SL; Gambhire MN; Kurmi SD; Kadam VJ; Jadhav KR
    Curr Drug Deliv; 2008 Jan; 5(1):32-41. PubMed ID: 18220549
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pluronic® F-127 and Pluronic Lecithin Organogel (PLO): main features and their applications in topical and transdermal administration of drugs.
    Almeida H; Amaral MH; Lobão P; Lobo JM
    J Pharm Pharm Sci; 2012; 15(4):592-605. PubMed ID: 23106961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and characterization of pluronic lecithin organogel containing fluocinolone acetonide.
    Patel D; Patel V
    Drug Dev Ind Pharm; 2021 Mar; 47(3):377-384. PubMed ID: 33493079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel composite fatty acid vesicles-in-Pluronic lecithin organogels for enhanced magnolol delivery in skin cancer treatment.
    Atef B; Ishak RAH; Badawy SS; Osman R
    Eur J Pharm Biopharm; 2024 Aug; 201():114379. PubMed ID: 38908488
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the stability of fluoxetine in pluronic lecithin organogel and the determination of an appropriate beyond-use date.
    Peacock GF; Sauvageot J
    Int J Pharm Compd; 2014; 18(3):253-5. PubMed ID: 25306774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of Pluronic lecithin organogels in the transdermal delivery of drugs.
    Bramwell BL; Williams LA
    Int J Pharm Compd; 2012; 16(1):62-3. PubMed ID: 23050314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.